English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 263 Help

  Show only claimed items
Selected(0)Clear Items/Page:    Sort:
CD4+ Foxp3+ Regulatory T-cells in Modulating Inflammatory Microenvironment in Chronic Rhinosinusitis with Nasal Polyps: Progress and Future Prospect Journal article
M Yusoff, Nur Najwa Farahin, Ahmad, Suhana, Wan Abdul Rahman, Wan Faiziah, Mohamud, Rohimah, C.Boer, Jennifer, Plebanski, Magdalena, Abdullah, Baharudin, Chen, Xin, Tengku Din, Tengku Ahmad Damitri Al Astani. CD4+ Foxp3+ Regulatory T-cells in Modulating Inflammatory Microenvironment in Chronic Rhinosinusitis with Nasal Polyps: Progress and Future Prospect[J]. Cytokine, 2024, 178, 156557.
Authors:  M Yusoff, Nur Najwa Farahin;  Ahmad, Suhana;  Wan Abdul Rahman, Wan Faiziah;  Mohamud, Rohimah;  C.Boer, Jennifer; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.7/3.5 | Submit date：2024/05/16
Crswnp  Immune Tolerance  t Regulatory Cell  Tnfr2  
Tolerogenic dendritic cell-mediated regulatory T cell differentiation by Chinese herbal formulation attenuates colitis progression Journal article
Huang, Chunhua, Lyu, Cheng, Mok, Heung Lam, Xu, Yiqi, Cheng, Ka Wing, Zhang, Cheng, Hu, Die, Zhu, Lin, Lin, Chengyuan, Chen, Xin, Tan, Hor Yue, Bian, Zhaoxiang. Tolerogenic dendritic cell-mediated regulatory T cell differentiation by Chinese herbal formulation attenuates colitis progression[J]. Journal of Advanced Research, 2024.
Authors:  Huang, Chunhua;  Lyu, Cheng;  Mok, Heung Lam;  Xu, Yiqi;  Cheng, Ka Wing; et al.
Favorite | TC[Scopus]:0  IF:11.4/11.0 | Submit date：2024/05/16
Ulcerative Colitis  Chinese Herbal Formulation  Cdd-2103  Tolerogenic Dendritic Cell  Regulatory t Cell  Oxidative Phosphorylation  
Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor Journal article
Wang, Mengjiao, Wan, Quan, Wang, Chenglv, Jing, Qianyu, Nie, Yujie, Zhang, Xiangyan, Chen, Xin, Yang, De, Pan, Runsang, Li, Linzhao, Zhu, Lan, Gui, Huan, Chen, Shuanghui, Deng, Yuezhen, Chen, Tao, Nie, Yingjie. Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor[J]. Molecular and Cellular Biochemistry, 2024.
Authors:  Wang, Mengjiao;  Wan, Quan;  Wang, Chenglv;  Jing, Qianyu;  Nie, Yujie; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.5/3.3 | Submit date：2024/05/16
Combination Immunotherapy  Hmgn1  Immunosuppression  R848  Α-tnfr2  
中醫藥免疫調節作用機制之探討 Presentation
会议地点: 澳大-湖北中醫藥大學中醫藥傳承與創新研討會, 报告日期: 2024-01-01
Authors:  CHEN XIN
Favorite |  | Submit date：2024/08/29
Targeting of TNFR2 for immunotherapy Presentation
会议地点: 2024 International Forum on Advanced Health Engineering, SIGS, Shenzhen, China, 报告日期: 2024-01-01
Authors:  CHEN XIN
Favorite |  | Submit date：2024/08/29
TNFR2 as an Emerging Target for the Treatment of Cancer and Autoimmune Diseases: Rooted in Chinese Medicine and Applied in Chinese Medicine Research Presentation
会议地点: 2024年世界針灸學會聯合會中醫針灸科研學術研討會 粵港澳高校針灸聯盟成立大會, 报告日期: 2024-01-01
Authors:  CHEN XIN
Favorite |  | Submit date：2024/08/29
Cellular and molecular mechanisms of immune modulatory effect of Chinese medicine Presentation
会议地点: Institute of Immunology, Hsinghua Univesrity Medical School, Beijing, China, 报告日期: 2023-12-18
Authors:  CHEN XIN
Favorite |  | Submit date：2024/08/29
Targeting of TNFR2 in the treatment of cancer and autoimmune diseases Presentation
会议地点: Institute of Immunology, Hsinghua Univesrity Medical School, Beijing, China, 报告日期: 2023-12-18
Authors:  CHEN XIN
Favorite |  | Submit date：2024/08/29
TNFR2-targeting in the treatment of cancer and autoimmune diseases: recent progress Presentation
会议地点: Sichuan Society for Immunology Annual Meeting (Dec 10, 2023, Chengdu, Sichuan, China), 报告日期: 2023-12-10
Authors:  CHEN XIN
Favorite |  | Submit date：2024/08/29
TNFR2 as an Emerging Target for the Treatment of Cancer and Autoimmune Diseases: Rooted in Chinese Medicine and Applied in Chinese Medicine Research Presentation
会议地点: The 12th Pong Ding Yuen International Symposium on Chinese Medicine (THE UNIVERSITY OF HONG KONG, SCHOOL OF CHINESE MEDICINE), 报告日期: 2023-11-25
Authors:  CHEN XIN
Favorite |  | Submit date：2024/08/29